TABLE 1

Demographic and functional characteristics of the study population based on the Global Initiative for Chronic Obstructive Lung Disease 2011 strategy

CharacteristicsAllGroup AGroup BGroup CGroup Dp-value
Patients n60914259134274 
Males557 (91.5)130 (91.5)52 (88.1)124 (92.5)251 (91.6)0.801
Age years mean±sd71.5±9.170.3±9.872.7±8.771.8±8.771.6±8.90.551
BMI kg·m−226.5 (24.1–31.3)28.8 (25.4–30.5)25.8 (24.9–29.3)28.4 (24.6–31.3)25.2 (21.6– 31.9)0.002
Current smokers163 (26.8)42 (29.6)19 (32.2)40 (29.9)62 (22.6)0.089
Smoking history pack-years60.0 (50.0–90.0)60.0 (50.0–80.0)75.0 (56.0–100.0)70.0 (55.0–92.5)60.0 (50.0–82.5)0.014
FEV1 % pred52.4±19.969.6±14.467.7±13.853.9±16.139.5±15.2<0.001
Charlson comorbidity index score3.0 (2.0–4.0)2.0 (1.0–3.0)3.0 (2.0–3.0)3.0 (1.0–4.0)3.0 (2.0–4.0)<0.001
CVD331 (54.4)45 (31.7)19 (32.2)65 (48.5)202 (73.7)<0.001
DM195 (32.0)14 (9.9)21 (35.6)31 (23.1)127 (47.1)<0.001
AH410 (67.3)79 (55.6)28 (47.5)99 (73.9)204 (74.5)<0.001
Patients with AECOPD#472 (77.5)87 (61.3)35 (59.3)106 (79.1)244 (89.1)<0.001
AECOPD per patient per year#2.0 (1.0–3.0)1.0 (0.0–1.0)2.0 (0.0–3.0)2.0 (1.0–3.0)3.0 (2.0–5.0)<0.001
Patients with hospitalisations#290 (47.6)34 (23.9)22.0 (37.3)53.0 (39.6)181 (66.1)<0.001
Hospitalisations per patient per year#0.0 (0.0–2.0)0.0 (0.0–0.0)0.0 (0.0–1.0)0.0 (0.0–1.0)1.0 (0.0–2.0)<0.001
  • Data are presented as n (%), mean±sd or median (interquartile range), unless otherwise stated. BMI: body mass index; FEV1: forced expiratory volume in 1 s; CVD: cardiovascular disease; DM: diabetes mellitus; AH: arterial hypertension; AECOPD: acute exacerbations of chronic obstructive pulmonary disease. #: events in the 1-year follow-up. Bold indicates statistical significance.